Daniel Jeffrey Moore

Daniel Jeffrey Moore (board member) discloses dealings in 3 companies, chiefly LivaNova PLC, ViewRay, Inc. and TriVascular Technologies, Inc. In total, 22 filings cover trades dated from 15 January 2016 to 3 June 2024.

In open-market terms, that means 1 purchase worth €237k on one side and 10 sales worth €651k on the other. The amount is not disclosed for 1 filing. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 5 share grants and 5 option exercises.

On 5 June 2024 came the latest disclosure, an option exercise for €3.0M in LivaNova PLC. The last insider purchase was made public on 12 May 2022, 1,620 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.